250 related articles for article (PubMed ID: 6124256)
1. Comparison of the apparent irreversible beta-adrenoceptor antagonist Ro 03-7894 with propranolol in cardiac ventricular muscle by pharmacological and radioligand binding techniques.
Rankin A; Broadley KJ
Biochem Pharmacol; 1982 Apr; 31(7):1325-32. PubMed ID: 6124256
[TBL] [Abstract][Full Text] [Related]
2. beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.
Hawthorn MH; Broadley KJ
Naunyn Schmiedebergs Arch Pharmacol; 1982 Sep; 320(3):240-5. PubMed ID: 6290902
[TBL] [Abstract][Full Text] [Related]
3. Relationship between the (--)-[3H]-dihydroalprenolol binding to beta-adrenoceptors and transmembrane 86Rb efflux of the BC3H1 nonfusing muscle cell line.
Mauger JP; Worcel M
Br J Pharmacol; 1980 Apr; 68(4):731-9. PubMed ID: 6103725
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
Giudicelli Y; Lacasa D; Agli B
Biochim Biophys Acta; 1982 Mar; 715(1):105-15. PubMed ID: 6122470
[TBL] [Abstract][Full Text] [Related]
5. Comparative studies with the enantiomers of the glycol metabolite of propranolol and their effects on the cardiac beta-adrenoceptor.
Ogg GD; Neilson DG; Stevenson IH; Lyles GA
J Pharm Pharmacol; 1987 May; 39(5):378-83. PubMed ID: 2886586
[TBL] [Abstract][Full Text] [Related]
6. Whether phenylephrine exerts inotropic effects through alpha- or beta-adrenoceptors depends upon the relative receptor populations.
Chess-Williams RG; Williamson KL; Broadley KJ
Fundam Clin Pharmacol; 1990; 4(1):25-37. PubMed ID: 2160415
[TBL] [Abstract][Full Text] [Related]
7. Is Ro 03-7894 an irreversible antagonist at beta-adrenoceptor sites?
Krstew E; McPherson GA; Malta E; Molenaar P; Raper C
Br J Pharmacol; 1984 Jun; 82(2):501-8. PubMed ID: 6145474
[TBL] [Abstract][Full Text] [Related]
8. Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist.
Broadley KJ; Nicholson CD
Br J Pharmacol; 1981 Apr; 72(4):635-43. PubMed ID: 6116509
[TBL] [Abstract][Full Text] [Related]
9. Temperature-induced changes in dissociation constants (KA) of agonists at cardiac beta-adrenoceptors determined by use of the irreversible antagonist Ro 03-7894.
Broadley KJ; Williams RG
Br J Pharmacol; 1983 Jun; 79(2):517-24. PubMed ID: 6140043
[TBL] [Abstract][Full Text] [Related]
10. Characterization of beta-adrenergic receptors in the rat vas deferens using [3H]-dihydroalprenolol binding.
Chang RS; Lotti VJ
Life Sci; 1983 May; 32(22):2603-9. PubMed ID: 6134224
[TBL] [Abstract][Full Text] [Related]
11. Phenylethanolaminotetralines compete with [3H]dihydroalprenolol binding to rat colon membranes without evidencing atypical beta-adrenergic sites.
Landi M; Bianchetti A; Croci T; Manara L
Biochem Pharmacol; 1992 Aug; 44(4):665-72. PubMed ID: 1354964
[TBL] [Abstract][Full Text] [Related]
12. Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.
Kaumann AJ; Lemoine H
Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):27-39. PubMed ID: 2866449
[TBL] [Abstract][Full Text] [Related]
13. The effect of the beta-adrenoreceptor antagonist Ro03-7894 on rat atrial tension development and (-)-[3H]dihydroalprenolol binding to cardiac and lung membranes.
Baker SP; Posner P
Life Sci; 1983 Aug; 33(5):459-66. PubMed ID: 6135967
[TBL] [Abstract][Full Text] [Related]
14. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
15. In vitro characterization of skeletal muscle beta-adrenergic receptors coupled to adenylate cyclase.
Reddy NB; Engel WK
Biochim Biophys Acta; 1979 Jul; 585(3):343-59. PubMed ID: 226166
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
Kawai Y; Graham SM; Yoshioka H; Arinze IJ
Biochem Pharmacol; 1986 Dec; 35(24):4387-93. PubMed ID: 3024648
[TBL] [Abstract][Full Text] [Related]
17. Determination of agonist affinity for cardiac beta-adrenoceptors during reserpine-induced supersensitivity.
Williams RG; Broadley KJ
Eur J Pharmacol; 1983 Jan; 87(1):95-105. PubMed ID: 6132824
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):201-10. PubMed ID: 2546050
[TBL] [Abstract][Full Text] [Related]
19. Presence of ectopic beta-adrenergic receptors on human adrenocortical cortisol-producing adenomas.
Hirata Y; Uchihashi M; Sueoka S; Matsukura S; Fujita T
J Clin Endocrinol Metab; 1981 Nov; 53(5):953-7. PubMed ID: 6270185
[TBL] [Abstract][Full Text] [Related]
20. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
